Wyeth Pharmaceuticals Inc.
Overview
Wyeth Pharmaceuticals Inc. is a subsidiary of Pfizer Inc., a leading global pharmaceutical company. Wyeth is renowned for its contributions to the development and manufacturing of innovative health solutions across various therapeutic areas, offering a diverse portfolio of drugs and vaccines.
Therapeutic areas
Active pharmaceutical ingredients supplied
Substances Wyeth Pharmaceuticals Inc. is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Wyeth Pharmaceuticals Inc. holds 0 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- BONE MORPHOGENETIC PROTEIN-2 (HUMAN, RECOMBINANT, CHO CELLS, WYETH)Inactive2002-09-06
- DEMECLOCYCLINE HYDROCHLORIDEInactive1998-09-01
- FACILITIES AND OPERATING PROCEDURES IN MUENSTER, WEST GERMANYInactive1990-01-31
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Wyeth Pharmaceuticals Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Wyeth Pharmaceuticals Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.